First Hawaiian enters the back half of July with a familiar tension: a stock down 3.3% on the week and 5% over the past month, yet with analysts nudging targets modestly higher after a post-earnings reset.
The catalyst is recent. The bank reported Q2 results on July 24, and the stock dropped 3% on the day — a meaningful one-day reaction that has compressed the price to $28.09. What followed was a burst of analyst activity, all in the same direction: targets lifted, ratings unchanged. TD Cowen cut its target from $32 to $31 while holding at Hold. Stephens raised to $32 from $28. Piper Sandler moved to $30 from $29. The message from the Street is consistent — upside is modest, conviction is low. Goldman Sachs, notably, maintained its Sell rating even as it lifted its target to $30, keeping FHB on its negative list at a price that is now only a dollar below that target. The mean consensus target of $30.67 implies roughly 9% upside from current levels, but the overwhelming weight of coverage sits at neutral-to-negative ratings. This is not a stock the Street is chasing.
Short positioning is elevated but not extreme, and the borrow market is nowhere near stressed. Short interest runs at 9.3% of the free float — real, but easing. It has fallen roughly 3% over the week and nearly 6% over the past month, tracking the modest decline in share price rather than building against it. Borrow availability is exceptionally loose at 1,770%, meaning there are roughly 17 shares available to lend for every share already borrowed. Cost to borrow has ticked up about 16% over the past month to 0.49%, but at that level it remains well within the "easy borrow" category. The combination tells a clear story: shorts are not pressing, and new short sellers face no friction entering the trade.
Options positioning reinforces the cautious-but-not-panicked tone. The put/call ratio at 2.0 sits essentially in line with its 20-day average of 1.98, with a z-score near zero — no unusual hedging demand ahead of or after the earnings release. The 52-week range on PCR is extraordinarily wide (0.05 to 20.35), so the current reading says little about extremes. What it does confirm is that options traders are neither rushing to protect downside nor adding speculative upside exposure. The position is quiet.
The bull-bear debate on FHB is fairly well defined. Bulls point to Hawaii's largest bank franchise, an enviable deposit cost of 1.20%, and a balance sheet that supports potential mainland acquisition targets in the $2–$15 billion asset range. Bears focus on the structural dependency on Hawaiian tourism and defense spending — both cyclically vulnerable — combined with persistent loan growth weakness and the margin pressure that comes with a lower-rate environment. Valuation sits at roughly 11.5x trailing earnings and 1.04x book, neither stretched nor compelling. The dividend score ranks in the 76th percentile of the universe, consistent with the bank's history of steady $0.26 quarterly payouts, though dividend data beyond 2022 is not available to verify current policy. The short score of 51.9 is middling and has drifted lower from roughly 53 two weeks ago, consistent with the softening price momentum.
Peers offer a useful frame. BOH, the closest Hawaii-market comparable, fell harder on the week — down 5.1% against FHB's 3.3% — suggesting the post-earnings weakness is partly sector-wide among Hawaii-exposed regionals. BOKF and CBSH, both mainland regionals with high correlation to FHB, gained on the week, highlighting that FHB's underperformance has a Hawaii-specific component rather than being purely a regional-bank story.
With no next earnings date yet announced, what to watch is whether the Street's post-earnings target creep — modest upgrades across the board with ratings anchored at neutral — attracts any incremental institutional buying, or whether the stock continues to drift in the gap between a $28 price and a $30–$32 target cluster that analysts seem reluctant to defend with a conviction rating.
See the live data behind this article on ORTEX.
Open FHB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
